The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors (DPT02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04482309
Recruitment Status : Active, not recruiting
First Posted : July 22, 2020
Last Update Posted : February 6, 2024
Daiichi Sankyo Co., Ltd.
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : June 8, 2023
Estimated Study Completion Date : July 30, 2027